| Date and Time | July 15, 2017 (Sat) 16:15-18:15 |
|---|---|
| venue | Cross Wave Umeda 1st floor large training room Address: 1-12 Kamiyamacho, Kita-ku, Osaka City, Osaka Prefecture TEL: 06-6312-3200 |
| Providing information | 16:15-16:30 SGLT2 inhibitor "Suglat Tablets" Astellas Pharma Inc. |
| General MC | Dr. Akihiro Hamasaki, Chief Director of the Diabetes and Endocrinology Center, Kitano Hospital |
| [Session 1] 16:40-17:15 | |
| Chair | Dr. Isao Saito, Chief of Ophthalmology, Kitano Hospital |
| Lecture 1 | "Kitano Hospital's New Discharge Support Initiative" Dr. Yoko Sugiuchi, Chief Nurse, Kitano Hospital Community Medical Service Center |
| Lecture 2 | "Introduction to Kitano Hospital's Diabetes Classes, Open to Anyone" Lecturer, Department of Physical Therapy, Faculty of Health and Medical Sciences, Morinomiya University of Health Sciences (Concurrently) Kitano Hospital Diabetes and Endocrinology Center Physical Therapist Dr. Akihiro Tsunoda |
| [Session 2] 17:15-18:15 | |
| Chair | Dr. Jun Minamikawa, Director of Minamikawa Clinic |
| Lecture | "Prospects and challenges of regional collaborative treatment for chronic kidney disease" |
| performer | Dr. Tatsuo Tsukamoto, Chief of Nephrology, Kitano Hospital |
Co-hosted by: Kitano Diabetes Complications Medical Collaboration Association and Astellas Pharma Inc.
*Light snacks are available.
*This lecture has been applied for as 2 credits for the Osaka Prefectural Medical Association's Continuing Education Course.
If you are able to attend, please contact us at the address below.
Kitano Hospital Community Medical Service Center
Phone number: 06-6131-2955